Satsuma Pharmaceuticals, Inc. Total Liabilities
Satsuma Pharmaceuticals, Inc. had Total Liabilities of $5.83 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2023-05-11
- 2023-03-31: Liabilities $5.83M.
- 2022-12-31: Liabilities $8.12M.
- 2022-09-30: Liabilities $6.66M.
- 2022-06-30: Liabilities $7.96M.
| Period end | Liabilities |
|---|---|
| 2023-03-31 | $5.83M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.12M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $6.66M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.96M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.69M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $8.49M 10-K · filed 2023-03-28 |
| 2021-09-30 | $6.62M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.58M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $5.91M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $9.10M 10-K · filed 2022-03-15 |
| 2020-09-30 | $9.23M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $8.68M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $9.73M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $10.94M 10-K · filed 2021-03-25 |
| 2019-09-30 | $9.42M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $6.87M 10-K · filed 2020-03-10 |